ACTL10 and acute myeloid leukemia: In conclusion, high RNA expression levels of ACTL10 and a low DNA methylation status of ACTL10 was found to predict an improved prognosis in patients with CN-AML, irrespective of whether the patient received chemotherapy or allogeneic hematopoietic stem cell transplantation.